If, like this Kat, you love all things pharma, biotech and patents, then the Pharma & Biotech Patent Litigation in Europe conference is for you. The IPKat is also happy to report that there is a special 10% discount in the registration fee, with discount code: D10-999-IPKAT26.
 |
Catching up on pharma IP case law
in Amsterdam |
The conference will be held over 2 days in central Amsterdam. Highlights on the agenda this year include:
- The Rise of Cross-Border Patent Enforcement: Redesigning European Patent Litigation Strategy Post-BSH v Electrolux.
- Running and Defending Preliminary Injunctions at the UPC and Beyond: Reconciling Diverging Standards and Making Strategic Choices for Life Sciences.
- Antibody Patent Prosecution in the EU and the US.
- The Doctrine of Equivalence: Balancing the UPC's First Approach Against Contrasting UK and German Decisions.
- Claim Interpretation, Description Conflicts, and the Next Chapter in Life Sciences after G 1/24 and G 1/25.
- Regulatory Exclusivities and IP After the EU Pharma Package: Key Takeaways for Industry and Litigators.
- Skinny Labels as a Safe Harbour? Second Medical Use Patents and Evolving Infringement Liability in Europe and the US.
More details and registration on the conference
website.
